Clinical and experimental immunology - JoVE Visualize

Showing results (381-390 of 13,508) with videos related to

Pageof 1,351

Sort By:

Clinical and Experimental Immunology|November 25, 2000

Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosisT Yamano, T Higashi, K Nouso, et al.

Clinical and Experimental Immunology|November 25, 2000

Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cellsA Prasse, C G Georges, H Biller, et al.

Clinical and Experimental Immunology|November 25, 2000

Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpuraY H Yang, M T Huang, S C Lin, et al.

Clinical and Experimental Immunology|October 30, 1999

The modulation of B7.2 and B7.1 on B cells by immunosuppressive agentsO Jirapongsananuruk, D Y Leung

Clinical and Experimental Immunology|October 30, 1999

Effect of different sensitizing doses of antigen in a murine model of atopic asthmaK Sakai, A Yokoyama, N Kohno, et al.

Clinical and Experimental Immunology|October 30, 1999

Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane proteinD Vanrompay, E Cox, G Volckaert, et al.

Clinical and Experimental Immunology|October 30, 1999

HLA-DRB1 leprogenic motifs in nigerian population groupsG P Uko, L Y Lu, M A Asuquo, et al.

Clinical and Experimental Immunology|October 30, 1999

Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitisP D Hodgson, M D Grant, T I Michalak

Clinical and Experimental Immunology|October 30, 1999

Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathwayA Kaser, B Enrich, O Ludwiczek, et al.

Clinical and Experimental Immunology|October 30, 1999

Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapyN Imami, G A Hardy, M R Nelson, et al.

Pageof 1,351

Showing results (381-390 of 13,508) with videos related to

Sort By:

Pageof 1,351

Clinical and Experimental Immunology|November 25, 2000

Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosisT Yamano, T Higashi, K Nouso, et al.

Clinical and Experimental Immunology|November 25, 2000

Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cellsA Prasse, C G Georges, H Biller, et al.

Clinical and Experimental Immunology|November 25, 2000

Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpuraY H Yang, M T Huang, S C Lin, et al.

Clinical and Experimental Immunology|October 30, 1999

The modulation of B7.2 and B7.1 on B cells by immunosuppressive agentsO Jirapongsananuruk, D Y Leung

Clinical and Experimental Immunology|October 30, 1999

Effect of different sensitizing doses of antigen in a murine model of atopic asthmaK Sakai, A Yokoyama, N Kohno, et al.

Clinical and Experimental Immunology|October 30, 1999

Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane proteinD Vanrompay, E Cox, G Volckaert, et al.

Clinical and Experimental Immunology|October 30, 1999

HLA-DRB1 leprogenic motifs in nigerian population groupsG P Uko, L Y Lu, M A Asuquo, et al.

Clinical and Experimental Immunology|October 30, 1999

Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitisP D Hodgson, M D Grant, T I Michalak

Clinical and Experimental Immunology|October 30, 1999

Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathwayA Kaser, B Enrich, O Ludwiczek, et al.

Clinical and Experimental Immunology|October 30, 1999

Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapyN Imami, G A Hardy, M R Nelson, et al.

Pageof 1,351